Did You Know?

Editor’s Picks

Latest News

ChemoCentryx Announces Presentation at the Society for Investigative Dermatology Meeting Highlighting the Role of Tunnels in Driving Ongoing Disease in Hidradenitis Suppurativa

-- Supports plans to advance TAVNEOS®(avacopan) into Phase III development for the treatment of patients with most severe form of...

error: Content is protected !!